The stages of type 1A diabetes: 2005
暂无分享,去创建一个
[1] W. Caspary,et al. Celiac disease , 2006, Orphanet journal of rare diseases.
[2] G. Eisenbarth,et al. The Stages of Type 1A Diabetes , 2005, Annals of the New York Academy of Sciences.
[3] G. Eisenbarth,et al. Analysis of children with type 1 diabetes in Korea: high prevalence of specific anti-islet autoantibodies, immunogenetic similarities to Western populations with "unique" haplotypes, and lack of discrimination by aspartic acid at position 57 of DQB. , 2004, Clinical immunology.
[4] M. Rewers,et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). , 2004, The Journal of clinical endocrinology and metabolism.
[5] J. She,et al. A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes , 2004, Nature Genetics.
[6] G. Eisenbarth,et al. Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes. , 2004, Journal of autoimmunity.
[7] Heather J Cordell,et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. , 2004, The Journal of clinical endocrinology and metabolism.
[8] J. Wasfy. Childhood vaccination and type 1 diabetes. , 2004, The New England journal of medicine.
[9] T. Tuvemo,et al. Enterovirus infections with β‐cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies , 2004, Journal of medical virology.
[10] J. Bilbao,et al. Prospective Population Screening for Celiac Disease: High Prevalence in the First 3 Years of Life , 2004, Journal of pediatric gastroenterology and nutrition.
[11] A. Ide,et al. Genetic differentiation of poly I:C from B:9-23 peptide induced experimental autoimmune diabetes. , 2004, Journal of autoimmunity.
[12] M. Rewers,et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. , 2004, Diabetes care.
[13] G. Eisenbarth,et al. Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. , 2004, Clinical immunology.
[14] M. Rewers,et al. Clinical features of children with screening-identified evidence of celiac disease. , 2004, Pediatrics.
[15] T. Ogihara,et al. Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to Type 1 diabetes in non-obese diabetic mice , 2004, Diabetologia.
[16] E. Gale. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes , 2004, The Lancet.
[17] H. Davidson,et al. HLA-DQ8-Associated T Cell Responses to the Diabetes Autoantigen Phogrin (IA-2β) in Human Prediabetes1 , 2004, The Journal of Immunology.
[18] Nunzio Bottini,et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes , 2004, Nature Genetics.
[19] H. Hyöty. Environmental causes: viral causes. , 2004, Endocrinology and metabolism clinics of North America.
[20] K. Herold. Treatment of type 1 diabetes mellitus to preserve insulin secretion. , 2004, Endocrinology and metabolism clinics of North America.
[21] P. Bingley,et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. , 2004, Diabetes.
[22] K. Klingel,et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells , 2004, Diabetologia.
[23] S. Pearce,et al. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. , 2003, The Journal of clinical endocrinology and metabolism.
[24] E. Bonifacio,et al. The Second Murine Autoantibody Workshop , 2003 .
[25] G. Eisenbarth,et al. Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse. , 2003, Journal of autoimmunity.
[26] E. Bonifacio,et al. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. , 2003, JAMA.
[27] M. Rewers,et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. , 2003, JAMA.
[28] M. Knip,et al. Intranasally administered insulin intended for prevention of type 1 diabetes—a safety study in healthy adults , 2003, Diabetes/metabolism research and reviews.
[29] J. Bluestone,et al. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes , 2003, Nature Medicine.
[30] G. Eisenbarth,et al. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Wildin,et al. Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T‐enriched splenocytes , 2003, Clinical and experimental immunology.
[32] H. Ochs,et al. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis , 2003, Current opinion in rheumatology.
[33] J. Shabanowitz,et al. Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] I. Cohen,et al. T cells and autoantibodies to human HSP70 in type 1 diabetes in children. , 2003, Journal of autoimmunity.
[35] Luc J. Smink,et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease , 2003, Nature.
[36] A. Hämäläinen,et al. Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial , 2003, Clinical and experimental immunology.
[37] C. Boitard,et al. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. , 2003, The Journal of clinical investigation.
[38] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[39] D. Finegood,et al. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. , 2003, The Journal of clinical investigation.
[40] J. Ilonen,et al. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes , 2002, Diabetologia.
[41] S. Rich,et al. Challenges and strategies for investigating the genetic complexity of common human diseases. , 2002, Diabetes.
[42] S. Honda,et al. During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities. , 2002, Clinical immunology.
[43] C. Boitard,et al. Normal renal function 8 to 13 years after Cyclosporin A therapy in 285 diabetic patients , 2002, Diabetes/metabolism research and reviews.
[44] Mark S. Anderson,et al. Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein , 2002, Science.
[45] J. Killestein. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. , 2002, The New England journal of medicine.
[46] F. Finkelman,et al. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. , 2002, The Journal of clinical investigation.
[47] J. K. Oeser,et al. Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein. , 2002, Journal of molecular endocrinology.
[48] J. Bach,et al. The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.
[49] A. Filipovich,et al. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome , 2002, Journal of medical genetics.
[50] M. Rewers,et al. Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease. , 2002, Tissue antigens.
[51] M. Atkinson. Heat shock protein therapy fails to prevent diabetes in NOD mice , 2002, Diabetologia.
[52] D. Wegmann,et al. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. , 2002, Diabetes.
[53] F. Mantero,et al. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. , 2002, Endocrine reviews.
[54] L. Peltonen,et al. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. , 2002, The Journal of clinical endocrinology and metabolism.
[55] L. Wen,et al. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[56] G. Eisenbarth,et al. Induction of Insulin Autoantibodies and Protection from Diabetes with Subcutaneous Insulin B: 9‐23 Peptide without Adjuvant , 2002, Annals of the New York Academy of Sciences.
[57] E. Bonifacio,et al. International Workshop on Lessons from Animal Models for Human Type 1 Diabetes , 2002, Annals of the New York Academy of Sciences.
[58] W. Hagopian,et al. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. , 2002, Diabetes care.
[59] L. Peltonen,et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. , 2002, Human molecular genetics.
[60] T. Ogihara,et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. , 2002, Diabetes.
[61] E. Husebye,et al. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. , 2002, The Journal of clinical endocrinology and metabolism.
[62] I. Cohen,et al. β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial , 2001, The Lancet.
[63] G. Eisenbarth,et al. Evidence That a Peptide Spanning the B-C Junction of Proinsulin Is an Early Autoantigen Epitope in the Pathogenesis of Type 1 Diabetes1 , 2001, The Journal of Immunology.
[64] Don C. Wiley,et al. Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes , 2001, Nature Immunology.
[65] G. Eisenbarth,et al. Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice. , 2001, Diabetes.
[66] Y. Matsuzawa,et al. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. , 2001, Diabetes.
[67] J. Bach. Protective role of infections and vaccinations on autoimmune diseases. , 2001, Journal of autoimmunity.
[68] C. Ricordi,et al. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. , 2001, Diabetes.
[69] G. Eisenbarth,et al. Heterogeneity of Type I diabetes: analysis of monozygotic twins in Great Britain and the United States , 2001, Diabetologia.
[70] L. Molinari,et al. Epidemiology of Type I diabetes mellitus in Switzerland: steep rise in incidence in under 5 year old children in the past decade , 2001, Diabetologia.
[71] K. Haskins,et al. Comparison of a T Cell Clone and of T Cells from a TCR Transgenic Mouse: TCR Transgenic T Cells Specific for Self-Antigen Are Atypical1 , 2001, The Journal of Immunology.
[72] Darrell M. Wilson,et al. First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. , 2001, The Journal of pediatrics.
[73] G. Eisenbarth,et al. Rapid assays for detection of anti-islet autoantibodies: implications for organ donor screening. , 2001, Journal of autoimmunity.
[74] A. Gaur,et al. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. , 2001, The Journal of clinical investigation.
[75] D. Wegmann,et al. It's insulin. , 2000, Journal of autoimmunity.
[76] J. Tuomilehto,et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. , 2000, Diabetes care.
[77] S. Tafuro,et al. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population , 2000, Nature.
[78] E. Unanue,et al. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. , 2000, Immunity.
[79] K. Garcia,et al. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. , 2000, Science.
[80] L. Harrison,et al. Lack of association between duration of breast-feeding or introduction of cow's milk and development of islet autoimmunity. , 1999, Diabetes.
[81] A. Arrieta,et al. Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease. , 1999, Journal of pediatric gastroenterology and nutrition.
[82] P. Brunetti,et al. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. , 1999, The Journal of clinical endocrinology and metabolism.
[83] C. Janeway,et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library , 1999, Nature Medicine.
[84] H. Weiner,et al. Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice. , 1999, Journal of immunology.
[85] M. Rewers,et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. , 1999, Journal of autoimmunity.
[86] M. Atkinson,et al. The NOD mouse model of type 1 diabetes: As good as it gets? , 1999, Nature Medicine.
[87] A. Ziegler,et al. Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: The German BABYDIAB study , 1999, Diabetologia.
[88] H. Erlich,et al. Sequence analysis of the diabetes-protective human leukocyte antigen-DQB1*0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.
[89] I. Mackay,et al. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43) , 1999, Diabetologia.
[90] S. Ziegler,et al. Cellular and molecular characterization of the scurfy mouse mutant. , 1999, Journal of immunology.
[91] H. Kolb,et al. Nicotinamide in type 1 diabetes. Mechanism of action revisited. , 1999, Diabetes care.
[92] C. Benoist,et al. Initiation of Autoimmune Diabetes by Developmentally Regulated Presentation of Islet Cell Antigens in the Pancreatic Lymph Nodes , 1999, The Journal of experimental medicine.
[93] H. Mcdevitt,et al. The role of MHC class II molecules in susceptibility and resistance to autoimmunity. , 1998, Current opinion in immunology.
[94] P. Bingley,et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. , 1998, Diabetes.
[95] M. Lan,et al. Ia-2 and IA-2β : The immune response in IDDM , 1998 .
[96] L. Peltonen,et al. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains , 1997, Nature Genetics.
[97] P. Charukamnoetkanok,et al. Thymic expression of autoantigens correlates with resistance to autoimmune disease. , 1997, Journal of immunology.
[98] E. Unanue,et al. Insights into the chemistry and biology of the I-Ag7 class II molecule. , 1997, Research in immunology.
[99] R. Joshi,et al. Phenotypic alterations in insulin-deficient mutant mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[100] J. Todd,et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus , 1997, Nature Genetics.
[101] Camillo Ricordi,et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes , 1997, Nature Genetics.
[102] G. Eisenbarth,et al. Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children. , 1996, Journal of autoimmunity.
[103] J. Hutton,et al. Identification of the 37-kDa Antigen in IDDM as a Tyrosine Phosphatase-Like Protein (Phogrin) Related to IA-2 , 1996, Diabetes.
[104] M. Rewers,et al. Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY) , 1996, JAMA.
[105] H. Chase,et al. Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies , 1996, Diabetes.
[106] R. Tisch,et al. The Role of MHC Class II Genes in Susceptibility and Resistance to Type I Diabetes Mellitus in the NOD Mouse , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[107] G. Eisenbarth,et al. Late Progression to Diabetes and Evidence for Chronic β-Cell Autoimmunity in Identical Twins of Patients With Type I Diabetes , 1995, Diabetes.
[108] H. Erlich,et al. HLA-DQB1*0602 Is Associated With Dominant Protection From Diabetes Even Among Islet Cell Antibody–Positive First-Degree Relatives of Patients with IDDM , 1995, Diabetes.
[109] D. Wegmann,et al. Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD mice , 1995, European journal of immunology.
[110] R. Gill,et al. Analysis of the spontaneous T cell response to insulin in NOD mice. , 1994, Journal of autoimmunity.
[111] P. Bingley,et al. Combined Analysis of Autoantibodies Improves Prediction of IDDM in Islet Cell Antibody-Positive Relatives , 1994, Diabetes.
[112] E. Bonifacio,et al. Antibodies to Islet 37k Antigen, But Not to Glutamate Decarboxylase, Discriminate Rapid Progression to IDDM in Endocrine Autoimmunity , 1994, Diabetes.
[113] A. Ariza,et al. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. , 1994, Journal of immunology.
[114] J. Ilonen,et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus , 1994, The New England journal of medicine.
[115] L. Velloso,et al. GAD Autoantibodies in IDDM, Stiff-Man Syndrome, and Autoimmune Polyendocrine Syndrome Type I Recognize Different Epitopes , 1994, Diabetes.
[116] D. Faustman,et al. Faulty Major Histocompatibility Complex Class II I-E Expression is Associated With Autoimmunity in Diverse Strains of Mice: Autoantibodies, Insulitis, and Sialadenitis , 1993, Diabetes.
[117] H. Kolb,et al. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. , 1992, The Journal of clinical endocrinology and metabolism.
[118] E. Bonifacio,et al. Distinct cytoplasmic islet cell antibodies with different risks for Type 1 (insulin-dependent) diabetes mellitus , 1992, Diabetologia.
[119] S. Bonner-Weir,et al. Prognostically Significant Heterogeneity of Cytoplasmic Islet Cell Antibodies in Relatives of Patients with Type I Diabetes , 1992, Diabetes.
[120] S. Brink,et al. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of Type 1 (insulin-dependent) diabetic patients , 1991, Diabetologia.
[121] B. Boehm,et al. Aspartic acid at position 57 of the HLA-DQβ chain is protective against future development of insulin-dependent (Type 1) diabetes mellitus , 1991, Klinische Wochenschrift.
[122] R E LaPorte,et al. Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[123] S. Baekkeskov,et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.
[124] D. Daneman,et al. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment , 1990, The Journal of experimental medicine.
[125] J. D. Capra,et al. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. , 1990, The New England journal of medicine.
[126] Y. Iwamoto,et al. High Frequency of Aspartic Acid at Position 57 of HLA-DQ β-Chain in Japanese IDDM Patients and Nondiabetic Subjects , 1990, Diabetes.
[127] E. Gale,et al. Rising Incidence of IDDM in Europe , 1989, Diabetes Care.
[128] R. Bergman,et al. Defects in β-Cell Function and Insulin Sensitivity in Normoglycemic Streptozocin-Treated Baboons: A Model of Preclinical Insulin-Dependent Diabetes* , 1988 .
[129] A. Ziegler,et al. Concentration of Insulin Autoantibodies at Onset of Type I Diabetes: Inverse Log-Linear Correlation With Age , 1988, Diabetes Care.
[130] G. Eisenbarth,et al. Congenital rubella. Monoclonal antibody-defined T cell abnormalities in young adults. , 1986, The American journal of medicine.
[131] G. Eisenbarth. Type I diabetes mellitus. A chronic autoimmune disease. , 1986 .
[132] W. Clarke,et al. Autoimmunity in congenital rubella syndrome. , 1984, The Journal of pediatrics.
[133] J. Palmer,et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. , 1983, Science.
[134] R. Gleason,et al. Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. , 1983, Annals of internal medicine.
[135] G. Eisenbarth,et al. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. , 1983, The New England journal of medicine.
[136] N. Maclaren,et al. Two Types of Autoimmune Addison's Disease Associated with Different Polyglandular Autoimmune (PGA) Syndromes , 1981, Medicine.
[137] D. Pyke,et al. Diabetes in identical twins , 1981, Diabetologia.
[138] G. Eisenbarth,et al. HLA type and occurrence of disease in familial polyglandular failure. , 1978, The New England journal of medicine.
[139] D. Doniach,et al. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.
[140] I. Doniach,et al. ISLETS OF LANGERHANS IN JUVENILE DIABETES MELLITUS , 1973, Clinical endocrinology.
[141] W. Gepts. Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus , 1965, Diabetes.
[142] G. A. Fleming,et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. , 2004, Diabetes.
[143] G. Eisenbarth,et al. Type 1 diabetes mellitus of man: genetic susceptibility and resistance. , 2004, Advances in experimental medicine and biology.
[144] Yan Zhang,et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. , 2004, Nature genetics.
[145] J. Todd,et al. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and –DRB1 , 2003, Genes and Immunity.
[146] H. Ochs,et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.
[147] I. Cohen,et al. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. , 2001, Lancet.
[148] M. Rewers,et al. DRB1104 and DQ Alleles: Expression of 21-Hydroxylase Autoantibodies and Risk of Progression to Addison’s Disease1 , 1999 .
[149] M. Rewers,et al. Addison’s Disease* , 2022 .
[150] M. Lan,et al. IA-2 and IA-2beta: the immune response in IDDM. , 1998, Diabetes Metabolism Reviews.
[151] P. Westermark. Pathology of the pancreas in diabetes mellitus , 1997 .
[152] H. Erlich,et al. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. , 1994, Human immunology.
[153] A. Tobin,et al. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. , 1993, The Journal of clinical investigation.
[154] J. Miyazaki,et al. Complete prevention of diabetes in transgenic NOD mice expressing I-E molecules. , 1992, Immunology letters.
[155] H. Erlich,et al. MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.
[156] W. Klitz,et al. HLA and insulin gene associations with IDDM , 1989, Genetic epidemiology.
[157] R. Bergman,et al. Defects in beta-cell function and insulin sensitivity in normoglycemic streptozocin-treated baboons: a model of preclinical insulin-dependent diabetes. , 1988, The Journal of clinical endocrinology and metabolism.
[158] A. Michael,et al. Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. , 1984, Transactions of the Association of American Physicians.